Loading the section…

MOLN: financial statements from SEC — TradeAlmanac

MOLN

Molecular Partners AG: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/12/2025	31/12/2024	31/12/2023	31/12/2022
Revenue	0	5M	7M	190M
Research and development	40M	49M	49M	51M
Selling, general and administrative	15M	18M	19M	22M
Operating income	−58M	−61M	−61M	117M
Pre-tax income	−62M	−54M	−62M	118M
Income tax	2,000	2,000	0	0
Net income	−62M	−54M	−62M	118M
Earnings per share	−1.65	−1.59	−1.89	3.63
Earnings per share, diluted	−1.65	−1.59	−1.89	3.54

Balance sheet

Metric	18/08/2026	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021
Cash and equivalents	—	83M	64M	67M	88M	72M
Receivables	—	2M	2M	2M	—	—

Cash flow

Metric	31/12/2025	31/12/2024	31/12/2023	31/12/2022
Operating cash flow	−51M	−59M	−59M	119M
Depreciation and amortisation	2M	2M	2M	2M
Share-based compensation	4M	4M	5M	5M
Capital expenditure

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator